tiprankstipranks
Trending News
More News >
Chordia Therapeutics Inc. (JP:190A)
:190A
Japanese Market

Chordia Therapeutics Inc. (190A) Financial Statements

Compare
2 Followers

Chordia Therapeutics Inc. Financial Overview

Chordia Therapeutics Inc.'s market cap is currently ¥8.75B. The company's EPS TTM is ¥-4.24; its P/E ratio is -5.80; Chordia Therapeutics Inc. is scheduled to report earnings on January 20, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 0.00¥ 0.00¥ 2.50B¥ 0.00¥ 800.00M
Gross Profit¥ -1.43B¥ -4.09M¥ 503.18M¥ -3.15M¥ 800.00M
Operating Income¥ -1.79B¥ -1.80B¥ 212.06M¥ -1.84B¥ -587.67M
EBITDA¥ -1.79B¥ -1.82B¥ 218.10M¥ -1.77B¥ -687.06M
Net Income¥ -1.79B¥ -1.83B¥ 223.34M¥ -1.78B¥ -527.11M
Balance Sheet
Cash & Short-Term Investments¥ 2.55B¥ 4.33B¥ 4.80B¥ 4.25B¥ 2.00B
Total Assets¥ 2.68B¥ 4.63B¥ 4.91B¥ 4.50B¥ 2.27B
Total Debt¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Net Debt¥ -2.55B¥ -4.33B¥ -4.80B¥ -4.25B¥ -2.00B
Total Liabilities¥ 244.34M¥ 471.07M¥ 408.24M¥ 221.41M¥ 214.95M
Stockholders' Equity¥ 2.44B¥ 4.16B¥ 4.50B¥ 4.28B¥ 2.06B
Cash Flow
Free Cash Flow¥ -1.84B¥ -1.94B¥ 543.01M¥ -1.72B¥ -546.92M
Operating Cash Flow¥ -1.84B¥ -1.94B¥ 543.73M¥ -1.70B¥ -544.59M
Investing Cash Flow¥ -5.33M¥ -10.96M¥ 345.00K¥ -14.70M¥ -2.36M
Financing Cash Flow¥ 61.58M¥ 1.48B¥ 0.00¥ 3.98B¥ 1.53B
Currency in JPY

Chordia Therapeutics Inc. Earnings and Revenue History

Chordia Therapeutics Inc. Debt to Assets

Chordia Therapeutics Inc. Cash Flow

Chordia Therapeutics Inc. Forecast EPS vs Actual EPS